Item 2.02 Other Events.

On March 28, 2023, Satsuma Pharmaceuticals, Inc. ("Satsuma" or the "Company") issued a press release announcing its financial results and recent business highlights for the fourth quarter and full year ended December 31, 2022, and its financial position as of December 31, 2022. The full text of the press release is furnished as Exhibit 99.1 hereto.

The information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, or incorporated by reference into any filings of the Company made under the Securities Act of 1933, as amended, regardless of any general incorporation language in the filing unless specifically stated so therein.

Item 9.01 Financial Statements and Exhibits.





Exhibit
  No.       Description

99.1          Press Release dated March 28, 2023

104         Cover Page Interactive Data File (embedded within the inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses